Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Parkinson's Disease

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 149 articles:
HTML format

Single Articles

    January 2022
  1. HASSIN-BAER S, Cohen OS, Israeli-Korn S, Yahalom G, et al
    Identification of an early-stage Parkinson's disease neuromarker using event-related potentials, brain network analytics and machine-learning.
    PLoS One. 2022;17:e0261947.
    PubMed     Abstract available

  2. PAMPHLETT R, Bishop DP
    Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson's disease and co-localises with Lewy bodies.
    PLoS One. 2022;17:e0262464.
    PubMed     Abstract available

  3. HATTORI N, Takeda A, Hanya Y, Kitagawa T, et al
    Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan.
    PLoS One. 2022;17:e0262796.
    PubMed     Abstract available

  4. GIGUERE-RANCOURT A, Plourde M, Racine E, Couture M, et al
    Goal management training and psychoeducation / mindfulness for treatment of executive dysfunction in Parkinson's disease: A feasibility pilot trial.
    PLoS One. 2022;17:e0263108.
    PubMed     Abstract available

  5. DIAZ K, Stegemoller EEL
    Electromyographic measures of asymmetric muscle control of swallowing in Parkinson's disease.
    PLoS One. 2022;17:e0262424.
    PubMed     Abstract available

  6. VALKONEN K, Makela JP, Airaksinen K, Nurminen J, et al
    Deep brain stimulation of subthalamic nucleus modulates cortical auditory processing in advanced Parkinson's Disease.
    PLoS One. 2022;17:e0264333.
    PubMed     Abstract available

  7. SHABAN M, Amara AW
    Resting-state electroencephalography based deep-learning for the detection of Parkinson's disease.
    PLoS One. 2022;17:e0263159.
    PubMed     Abstract available

  8. KELEMEN A, Halasz L, Eross L, Rudas G, et al
    Factors affecting postural instability after more than one-year bilateral subthalamic stimulation in Parkinson's disease: A cross-sectional study.
    PLoS One. 2022;17:e0264114.
    PubMed     Abstract available

  9. DISBROW EA, Glassy ND, Dressler EM, Russo K, et al
    Cortical oscillatory dysfunction in Parkinson disease during movement activation and inhibition.
    PLoS One. 2022;17:e0257711.
    PubMed     Abstract available

  10. HSU P, Ready EA, Grahn JA
    The effects of Parkinson's disease, music training, and dance training on beat perception and production abilities.
    PLoS One. 2022;17:e0264587.
    PubMed     Abstract available

  11. GONZALEZ-CASACUBERTA I, Vilas D, Pont-Sunyer C, Tobias E, et al
    Neuronal induction and bioenergetics characterization of human forearm adipose stem cells from Parkinson's disease patients and healthy controls.
    PLoS One. 2022;17:e0265256.
    PubMed     Abstract available

  12. FERRUCCI R, Mameli F, Ruggiero F, Reitano M, et al
    Alternate fluency in Parkinson's disease: A machine learning analysis.
    PLoS One. 2022;17:e0265803.
    PubMed     Abstract available

  13. SCHONENBERG A, Prell T
    Measuring quality of life with the Parkinson's Disease Questionnaire-39 in people with cognitive impairment.
    PLoS One. 2022;17:e0266140.
    PubMed     Abstract available

  14. LUCIEN F, Benarroch EE, Mullan A, Ali F, et al
    Poly (ADP-Ribose) and alpha-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity.
    PLoS One. 2022;17:e0264446.
    PubMed     Abstract available

  15. GULKE E, Alsalem M, Kirsten M, Vettorazzi E, et al
    Comparison of Montreal cognitive assessment and Mattis dementia rating scale in the preoperative evaluation of subthalamic stimulation in Parkinson's disease.
    PLoS One. 2022;17:e0265314.
    PubMed     Abstract available

  16. KOH J, Takahashi M, Ohmae Y, Taruya J, et al
    A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson's disease.
    PLoS One. 2022;17:e0266354.
    PubMed     Abstract available

  17. RUONALA V, Pekkonen E, Airaksinen O, Kankaanpaa M, et al
    Changes in elbow flexion EMG morphology during adjustment of deep brain stimulator in advanced Parkinson's disease.
    PLoS One. 2022;17:e0266936.
    PubMed     Abstract available

  18. JOVANOVIC P, Wang Y, Vit JP, Novinbakht E, et al
    Sustained chemogenetic activation of locus coeruleus norepinephrine neurons promotes dopaminergic neuron survival in synucleinopathy.
    PLoS One. 2022;17:e0263074.
    PubMed     Abstract available

  19. VIRBEL-FLEISCHMAN C, Retory Y, Hardy S, Huiban C, et al
    Body-Worn Sensors for Parkinson's disease: A qualitative approach with patients and healthcare professionals.
    PLoS One. 2022;17:e0265438.
    PubMed     Abstract available

  20. BAKKER M, Johnson ME, Corre L, Mill DN, et al
    Identifying rates and risk factors for medication errors during hospitalization in the Australian Parkinson's disease population: A 3-year, multi-center study.
    PLoS One. 2022;17:e0267969.
    PubMed     Abstract available

  21. MEDINA CA, Vargas E, Munger SJ, Miller JE, et al
    Vocal changes in a zebra finch model of Parkinson's disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathway.
    PLoS One. 2022;17:e0265604.
    PubMed     Abstract available

  22. GRAMOTNEV DK, Gramotnev G, Gramotnev A, Summers MJ, et al
    Path analysis of biomarkers for cognitive decline in early Parkinson's disease.
    PLoS One. 2022;17:e0268379.
    PubMed     Abstract available

  23. TROISI LOPEZ E, Minino R, Sorrentino P, Manzo V, et al
    Sensitivity to gait improvement after levodopa intake in Parkinson's disease: A comparison study among synthetic kinematic indices.
    PLoS One. 2022;17:e0268392.
    PubMed     Abstract available

  24. HILL A, Nantel J
    Sensitivity of discrete symmetry metrics: Implications for metric choice.
    PLoS One. 2022;17:e0268581.
    PubMed     Abstract available

  25. SONG J, Lee JH, Choi J, Suh MK, et al
    Detection and differentiation of ataxic and hypokinetic dysarthria in cerebellar ataxia and parkinsonian disorders via wave splitting and integrating neural networks.
    PLoS One. 2022;17:e0268337.
    PubMed     Abstract available

  26. LANDES RD, Glover A, Pillai L, Doerhoff S, et al
    Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype.
    PLoS One. 2022;17:e0269227.
    PubMed     Abstract available

  27. ZINNEN AD, Vichich J, Metzger JM, Gambardella JC, et al
    Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum.
    PLoS One. 2022;17:e0269190.
    PubMed     Abstract available

  28. CHONG-WEN W, Sha-Sha L, Xu E
    Predictors of rapid eye movement sleep behavior disorder in patients with Parkinson's disease based on random forest and decision tree.
    PLoS One. 2022;17:e0269392.
    PubMed     Abstract available

  29. MARKOVIC V, Stankovic I, Radovanovic S, Petrovic I, et al
    Gait alterations in Parkinson's disease at the stage of hemiparkinsonism-A longitudinal study.
    PLoS One. 2022;17:e0269886.
    PubMed     Abstract available

  30. GOLINSKA PB, Bieleninik L, Harciarek M, Bidzan M, et al
    The impact of cognitive impairment of individuals with Parkinson's disease on their caregivers' mental health: A systematic review protocol.
    PLoS One. 2022;17:e0271480.
    PubMed     Abstract available

  31. LI L, Ji B, Zhao T, Cui X, et al
    The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments.
    PLoS One. 2022;17:e0269787.
    PubMed     Abstract available

  32. READ J, Frost R, Walters K, Tuijt R, et al
    Transitions and challenges for people with Parkinson's and their family members: A qualitative study.
    PLoS One. 2022;17:e0268588.
    PubMed     Abstract available

  33. SONG MK, Adams L, Lee JH, Kim YS, et al
    NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-alpha-synuclein mouse model of Parkinson's disease.
    PLoS One. 2022;17:e0272085.
    PubMed     Abstract available

  34. HILL MA, Bentley SR, Walker TL, Mellick GD, et al
    Does a rare mutation in PTPRA contribute to the development of Parkinson's disease in an Australian multi-incident family?
    PLoS One. 2022;17:e0271499.
    PubMed     Abstract available

  35. HEARN R, Selfe J, Cordero MI, Dobbin N, et al
    The effects of active rehabilitation on symptoms associated with tau pathology: An umbrella review. Implications for chronic traumatic encephalopathy symptom management.
    PLoS One. 2022;17:e0271213.
    PubMed     Abstract available

  36. SONG S, Luo Z, Li C, Huang X, et al
    Depressive symptoms before and after Parkinson's diagnosis-A longitudinal analysis.
    PLoS One. 2022;17:e0272315.
    PubMed     Abstract available

  37. CHEN HC, Wang CY, Chen HH, Liou HH, et al
    Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson's disease when considering the coexisting effects of diabetes mellitus.
    PLoS One. 2022;17:e0269006.
    PubMed     Abstract available

  38. SHAH R, Read J, Davies N, Nimmons D, et al
    People with Parkinson's perspectives and experiences of self-management: Qualitative findings from a UK study.
    PLoS One. 2022;17:e0273428.
    PubMed     Abstract available

  39. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
    The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
    PLoS One. 2022;17:e0272559.
    PubMed     Abstract available

    Regulation of Parkinson's disease-associated genes by Pumilio proteins and microRNAs in SH-SY5Y neuronal cells.
    PLoS One. 2022;17:e0275235.
    PubMed     Abstract available

  41. DAS J, Morris R, Barry G, Vitorio R, et al
    Exploring the feasibility of technological visuo-cognitive training in Parkinson's: Study protocol for a pilot randomised controlled trial.
    PLoS One. 2022;17:e0275738.
    PubMed     Abstract available

  42. BARCENAS R, Fuentes-Garcia R, Naranjo L
    Mixed kernel SVR addressing Parkinson's progression from voice features.
    PLoS One. 2022;17:e0275721.
    PubMed     Abstract available

  43. RAZALI K, Mohd Nasir MH, Othman N, Doolaanea AA, et al
    Characterization of neurobehavioral pattern in a zebrafish 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced model: A 96-hour behavioral study.
    PLoS One. 2022;17:e0274844.
    PubMed     Abstract available

  44. TORRADO JC, Husebo BS, Allore HG, Erdal A, et al
    Digital phenotyping by wearable-driven artificial intelligence in older adults and people with Parkinson's disease: Protocol of the mixed method, cyclic ActiveAgeing study.
    PLoS One. 2022;17:e0275747.
    PubMed     Abstract available

  45. DE GOES MCR, Sarmento A, Lima I, Lyra M, et al
    After-effects of thixotropic conditionings on operational chest wall and compartmental volumes of patients with Parkinson's disease.
    PLoS One. 2022;17:e0275584.
    PubMed     Abstract available

  46. MIKOLAIZAK AS, Rochester L, Maetzler W, Sharrack B, et al
    Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocol.
    PLoS One. 2022;17:e0269615.
    PubMed     Abstract available

  47. BAKER S, Tekriwal A, Felsen G, Christensen E, et al
    Automatic extraction of upper-limb kinematic activity using deep learning-based markerless tracking during deep brain stimulation implantation for Parkinson's disease: A proof of concept study.
    PLoS One. 2022;17:e0275490.
    PubMed     Abstract available

  48. WAIRAGKAR M, Villeneuve E, King R, Janko B, et al
    A novel approach for modelling and classifying sit-to-stand kinematics using inertial sensors.
    PLoS One. 2022;17:e0264126.
    PubMed     Abstract available

  49. LAMA J, Salabasidou E, Volkmann J, Kuzkina A, et al
    Proinflammatory profile in the skin of Parkinson's disease patients with and without pain.
    PLoS One. 2022;17:e0276564.
    PubMed     Abstract available

  50. LOWIT A, Thies T, Steffen J, Scheele F, et al
    Task-based profiles of language impairment and their relationship to cognitive dysfunction in Parkinson's disease.
    PLoS One. 2022;17:e0276218.
    PubMed     Abstract available

  51. OWEN CL, Gaulton C, Roberts HC, Dennison L, et al
    Perceptions of people with Parkinson's and their caregivers of falling and falls-related healthcare services- a qualitative study.
    PLoS One. 2022;17:e0276588.
    PubMed     Abstract available

  52. KOMAGAMINE T, Suzuki K, Kokubun N, Komagamine J, et al
    Sleep-related hallucinations in patients with Parkinson's disease.
    PLoS One. 2022;17:e0276736.
    PubMed     Abstract available

  53. Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
    PLoS One. 2022;17:e0277781.
    PubMed     Abstract available

  54. BEK J, Leventhal D, Groves M, Growcott C, et al
    Moving online: Experiences and potential benefits of digital dance for older adults and people with Parkinson's disease.
    PLoS One. 2022;17:e0277645.
    PubMed     Abstract available

  55. VITORIO R, Morris R, Das J, Walker R, et al
    Brain activity response to cues during gait in Parkinson's disease: A study protocol.
    PLoS One. 2022;17:e0275894.
    PubMed     Abstract available

  56. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
    Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
    PLoS One. 2022;17:e0278279.
    PubMed     Abstract available

  57. JOLA C, Sundstrom M, McLeod J
    Benefits of dance for Parkinson's: The music, the moves, and the company.
    PLoS One. 2022;17:e0265921.
    PubMed     Abstract available

  58. DIERIKS BV, Highet B, Alik A, Bellande T, et al
    Human pericytes degrade diverse alpha-synuclein aggregates.
    PLoS One. 2022;17:e0277658.
    PubMed     Abstract available

  59. RAJA WK, Neves E, Burke C, Jiang X, et al
    Patient-derived three-dimensional cortical neurospheres to model Parkinson's disease.
    PLoS One. 2022;17:e0277532.
    PubMed     Abstract available

  60. HATORI Y, Kanda Y, Nonaka S, Nakanishi H, et al
    ATP13A2 modifies mitochondrial localization of overexpressed TOM20 to autolysosomal pathway.
    PLoS One. 2022;17:e0276823.
    PubMed     Abstract available

  61. NADEEM H, Zhou B, Goldman D, Romley J, et al
    Association between use of ss2-adrenergic receptor agonists and incidence of Parkinson's disease: Retrospective cohort analysis.
    PLoS One. 2022;17:e0276368.
    PubMed     Abstract available

    January 2021
  62. BOUSSAC M, Arbus C, Dupouy J, Harroch E, et al
    Personality dimensions of patients can change during the course of parkinson's disease.
    PLoS One. 2021;16:e0245142.
    PubMed     Abstract available

  63. KAMIENIARZ A, Michalska J, Marszalek W, Stania M, et al
    Detection of postural control in early Parkinson's disease: Clinical testing vs. modulation of center of pressure.
    PLoS One. 2021;16:e0245353.
    PubMed     Abstract available

  64. KITANI-MORII F, Kasai T, Horiguchi G, Teramukai S, et al
    Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan.
    PLoS One. 2021;16:e0245864.
    PubMed     Abstract available

  65. SHALASH AS, Hamid E, Elrassas H, Bahbah EI, et al
    Non-motor symptoms in essential tremor, akinetic rigid and tremor-dominant subtypes of Parkinson's disease.
    PLoS One. 2021;16:e0245918.
    PubMed     Abstract available

  66. FORNS J, Layton JB, Bartsch J, Turner ME, et al
    Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
    PLoS One. 2021;16:e0246121.
    PubMed     Abstract available

  67. PARK KH, Sun S, Lim YH, Park HR, et al
    Clinical outcome prediction from analysis of microelectrode recordings using deep learning in subthalamic deep brain stimulation for Parkinson`s disease.
    PLoS One. 2021;16:e0244133.
    PubMed     Abstract available

  68. MAHMOUDZADEH M, Wallois F, Tir M, Krystkowiak P, et al
    Cortical hemodynamic mapping of subthalamic nucleus deep brain stimulation in Parkinsonian patients, using high-density functional near-infrared spectroscopy.
    PLoS One. 2021;16:e0245188.
    PubMed     Abstract available

  69. LIN I, Edison B, Mantri S, Albert S, et al
    Triggers and alleviating factors for fatigue in Parkinson's disease.
    PLoS One. 2021;16:e0245285.
    PubMed     Abstract available

  70. SICA M, Tedesco S, Crowe C, Kenny L, et al
    Continuous home monitoring of Parkinson's disease using inertial sensors: A systematic review.
    PLoS One. 2021;16:e0246528.
    PubMed     Abstract available

  71. OVEISGHARAN S, Yu L, Bennett DA, Buchman AS, et al
    Incident mobility disability, parkinsonism, and mortality in community-dwelling older adults.
    PLoS One. 2021;16:e0246206.
    PubMed     Abstract available

  72. NAGANO T, Kakuma T, Umezu Y, Yanagawa T, et al
    Nutritional status and activities of daily living in patients with Parkinson's disease.
    PLoS One. 2021;16:e0246329.
    PubMed     Abstract available

  73. BURIL J, Burilova P, Pokorna A, Kovacova I, et al
    Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study.
    PLoS One. 2021;16:e0246342.
    PubMed     Abstract available

  74. Retraction: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats.
    PLoS One. 2021;16:e0247151.

  75. LEE JW, Song YS, Kim H, Ku BD, et al
    Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson's disease: Analysis of the PPMI data.
    PLoS One. 2021;16:e0246881.
    PubMed     Abstract available

  76. IIJIMA M, Okuma Y, Suzuki K, Yoshii F, et al
    Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson's disease: A multicenter cross-sectional study.
    PLoS One. 2021;16:e0247443.
    PubMed     Abstract available

  77. VARRECCHIA T, Castiglia SF, Ranavolo A, Conte C, et al
    An artificial neural network approach to detect presence and severity of Parkinson's disease via gait parameters.
    PLoS One. 2021;16:e0244396.
    PubMed     Abstract available

  78. AGURTO C, Heisig S, Abrami A, Ho BK, et al
    Parkinson's disease medication state and severity assessment based on coordination during walking.
    PLoS One. 2021;16:e0244842.
    PubMed     Abstract available

  79. BARGIOTAS I, Kalogeratos A, Limnios M, Vidal PP, et al
    Revealing posturographic profile of patients with Parkinsonian syndromes through a novel hypothesis testing framework based on machine learning.
    PLoS One. 2021;16:e0246790.
    PubMed     Abstract available

  80. DZIECIOL K, Iordanishvili E, Abbas Z, Nahimi A, et al
    A robust method for the detection of small changes in relaxation parameters and free water content in the vicinity of the substantia nigra in Parkinson's disease patients.
    PLoS One. 2021;16:e0247552.
    PubMed     Abstract available

  81. JEONG S, Cho H, Kim YJ, Ma HI, et al
    Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson's disease.
    PLoS One. 2021;16:e0247354.
    PubMed     Abstract available

  82. PHAM U, Skogseid IM, Pripp AH, Boen E, et al
    Impulsivity in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation-An exploratory study.
    PLoS One. 2021;16:e0248568.
    PubMed     Abstract available

  83. MANTRI S, Klawson E, Albert S, Rapoport R, et al
    The experience of care partners of patients with Parkinson's disease psychosis.
    PLoS One. 2021;16:e0248968.
    PubMed     Abstract available

  84. SEBATE B, Cuttler K, Cloete R, Britz M, et al
    Prioritization of candidate genes for a South African family with Parkinson's disease using in-silico tools.
    PLoS One. 2021;16:e0249324.
    PubMed     Abstract available

  85. LOVEGROVE CJ, Bannigan K
    What is the lived experience of anxiety for people with Parkinson's? A phenomenological study.
    PLoS One. 2021;16:e0249390.
    PubMed     Abstract available

  86. SIRAGY T, Hill A, Nantel J
    Recovery of dynamic stability during slips unaffected by arm swing in people with Parkinson's Disease.
    PLoS One. 2021;16:e0249303.
    PubMed     Abstract available

  87. Correction: A genetic analysis of a Spanish population with early onset Parkinson's disease.
    PLoS One. 2021;16:e0249805.
    PubMed     Abstract available

  88. JENSEN BR, Malling ASB, Schmidt SI, Meyer M, et al
    Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson's disease.
    PLoS One. 2021;16:e0248800.
    PubMed     Abstract available

  89. SORBERA C, Brigandi A, Cimino V, Bonanno L, et al
    The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.
    PLoS One. 2021;16:e0251313.
    PubMed     Abstract available

  90. KROTINGER A, Loui P
    Rhythm and groove as cognitive mechanisms of dance intervention in Parkinson's disease.
    PLoS One. 2021;16:e0249933.
    PubMed     Abstract available

  91. LOLEKHA P, Sriphanom T, Vilaichone RK
    Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial).
    PLoS One. 2021;16:e0251042.
    PubMed     Abstract available

  92. FREIDLE M, Johansson H, Lebedev AV, Ekman U, et al
    Measuring implicit sequence learning and dual task ability in mild to moderate Parkinson s disease: A feasibility study.
    PLoS One. 2021;16:e0251849.
    PubMed     Abstract available

  93. SHRESTHA S, Parks CG, Richards-Barber M, Chen H, et al
    Parkinson's disease case ascertainment in a large prospective cohort.
    PLoS One. 2021;16:e0251852.
    PubMed     Abstract available

  94. MCKAY JL, Lang KC, Bong SM, Hackney ME, et al
    Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease.
    PLoS One. 2021;16:e0252119.
    PubMed     Abstract available

  95. RODRIGUEZ-SABATE C, Rodriguez M, Morales I
    Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson's disease.
    PLoS One. 2021;16:e0252565.
    PubMed     Abstract available

  96. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
    Correction: Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
    PLoS One. 2021;16:e0252988.
    PubMed     Abstract available

  97. SHENG MZ, Fang TC, Chen YH, Chang MH, et al
    Is either anosmia or constipation associated with cognitive dysfunction in Parkinson's disease?
    PLoS One. 2021;16:e0252451.
    PubMed     Abstract available

  98. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    PubMed     Abstract available

  99. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    PubMed     Abstract available

  100. PEARCE P, Bulluss K, Xu SS, Kim B, et al
    How accurately are subthalamic nucleus electrodes implanted relative to the ideal stimulation location for Parkinson's disease?
    PLoS One. 2021;16:e0254504.
    PubMed     Abstract available

  101. KOYANAGI Y, Fukushi I, Nakamura M, Suzuki K, et al
    The effect of body weight-supported overground gait training for patients with Parkinson's disease: A retrospective case-control observational study.
    PLoS One. 2021;16:e0254415.
    PubMed     Abstract available

  102. TAGUCHI S, Koide H, Oiwa H, Hayashi M, et al
    Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
    PLoS One. 2021;16:e0255274.
    PubMed     Abstract available

  103. VACCARI C, Grotto D, Pereira TDV, de Camargo JLV, et al
    GLP-1 and GIP receptor agonists in the treatment of Parkinson's disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies.
    PLoS One. 2021;16:e0255726.
    PubMed     Abstract available

  104. WARDEN MN, Searles Nielsen S, Camacho-Soto A, Garnett R, et al
    A comparison of prediction approaches for identifying prodromal Parkinson disease.
    PLoS One. 2021;16:e0256592.
    PubMed     Abstract available

  105. ARISTOTELIDOU V, Tsatali M, Overton PG, Vivas AB, et al
    Autonomic factors do not underlie the elevated self-disgust levels in Parkinson's disease.
    PLoS One. 2021;16:e0256144.
    PubMed     Abstract available

  106. BRAKEDAL B, Tzoulis C, Tysnes OB, Haugarvoll K, et al
    NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study.
    PLoS One. 2021;16:e0256602.
    PubMed     Abstract available

  107. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
    Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
    PLoS One. 2021;16:e0257372.
    PubMed     Abstract available

  108. PARDOEL S, Shalin G, Lemaire ED, Kofman J, et al
    Grouping successive freezing of gait episodes has neutral to detrimental effect on freeze detection and prediction in Parkinson's disease.
    PLoS One. 2021;16:e0258544.
    PubMed     Abstract available

  109. AOUN K, Double KL, Pearson-Dennett V, Yilmaz R, et al
    Measurement of the adult human midbrain with transcranial ultrasound.
    PLoS One. 2021;16:e0247920.
    PubMed     Abstract available

  110. MA A, Lau KK, Thyagarajan D
    Radiological correlates of vocal fold bowing as markers of Parkinson's disease progression: A cross-sectional study utilizing dynamic laryngeal CT.
    PLoS One. 2021;16:e0258786.
    PubMed     Abstract available

  111. AHN JH, Seok JM, Park J, Jeong H, et al
    Validation of the Korean version of the composite autonomic symptom scale 31 in patients with Parkinson's disease.
    PLoS One. 2021;16:e0258897.
    PubMed     Abstract available

  112. PRELL T, Liebermann JD, Mendorf S, Lehmann T, et al
    Pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study.
    PLoS One. 2021;16:e0257966.
    PubMed     Abstract available

  113. BAILEY DK, Clark W, Kosman DJ
    The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PLoS One. 2021;16:e0254794.
    PubMed     Abstract available

  114. NEJTEK VA, James RN, Salvatore MF, Alphonso HM, et al
    Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease.
    PLoS One. 2021;16:e0258851.
    PubMed     Abstract available

  115. SHAMADYKOVA DV, Panteleev DY, Kust NN, Savchenko EA, et al
    Neuroinductive properties of mGDNF depend on the producer, E. Coli or human cells.
    PLoS One. 2021;16:e0258289.
    PubMed     Abstract available

  116. ELFARRASH S, Jensen NM, Ferreira N, Schmidt SI, et al
    Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
    PLoS One. 2021;16:e0252635.
    PubMed     Abstract available

  117. WITT VD, Baur G, Ecke J, Kirchner A, et al
    Parkinson's patients situation during the SARS CoV-2 pandemic and their interest in telemedicine A cross-sectional study.
    PLoS One. 2021;16:e0260317.
    PubMed     Abstract available

  118. DEL PINO R, Murueta-Goyena A, Ayala U, Acera M, et al
    Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease.
    PLoS One. 2021;16:e0259935.
    PubMed     Abstract available

  119. RICHARD P, Kozlowski L, Guillorit H, Garnier P, et al
    Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.
    PLoS One. 2021;16:e0253216.
    PubMed     Abstract available

  120. HAYNES JM, Sibuea SM, Aguiar AA, Li F, et al
    Inhibition of beta-catenin dependent WNT signalling upregulates the transcriptional repressor NR0B1 and downregulates markers of an A9 phenotype in human embryonic stem cell-derived dopaminergic neurons: Implications for Parkinson's disease.
    PLoS One. 2021;16:e0261730.
    PubMed     Abstract available

  121. VIRAMETEEKUL S, Phokaewvarangkul O, Bhidayasiri R
    Profiling the most elderly parkinson's disease patients: Does age or disease duration matter?
    PLoS One. 2021;16:e0261302.
    PubMed     Abstract available

  122. CUBO E, Garcia-Bustillo A, Arnaiz-Gonzalez A, Ramirez-Sanz JM, et al
    Adopting a multidisciplinary telemedicine intervention for fall prevention in Parkinson's disease. Protocol for a longitudinal, randomized clinical trial.
    PLoS One. 2021;16:e0260889.
    PubMed     Abstract available

  123. FRANSSON PA, Nilsson MH, Rehncrona S, Tjernstrom F, et al
    Deep brain stimulation in the subthalamic nuclei alters postural alignment and adaptation in Parkinson's disease.
    PLoS One. 2021;16:e0259862.
    PubMed     Abstract available

  124. MAKAI-BOLONI S, Thijssen E, van Brummelen EMJ, Groeneveld GJ, et al
    Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performance.
    PLoS One. 2021;16:e0260783.
    PubMed     Abstract available

  125. FRANKEMOLLE-GILBERT AM, Howell B, Bower KL, Veltink PH, et al
    Comparison of methodologies for modeling directional deep brain stimulation electrodes.
    PLoS One. 2021;16:e0260162.
    PubMed     Abstract available

    January 2020
  126. GAARE JJ, Nido G, Dolle C, Sztromwasser P, et al
    Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci.
    PLoS One. 2020;15:e0239824.
    PubMed     Abstract available

  127. SATO K, Mano T, Iwata A, Toda T, et al
    Autocorrelation-based method to identify disordered rhythm in Parkinson's disease tasks: A novel approach applicable to multimodal devices.
    PLoS One. 2020;15:e0238486.
    PubMed     Abstract available

  128. MONSELLIER E, Bendifallah M, Redeker V, Melki R, et al
    Polypeptides derived from alpha-Synuclein binding partners to prevent alpha-Synuclein fibrils interaction with and take-up by cells.
    PLoS One. 2020;15:e0237328.
    PubMed     Abstract available

  129. GLASS TJ, Kelm-Nelson CA, Szot JC, Lake JM, et al
    Functional characterization of extrinsic tongue muscles in the Pink1-/- rat model of Parkinson disease.
    PLoS One. 2020;15:e0240366.
    PubMed     Abstract available

  130. TANAKA R, Yamashiro K, Ogawa T, Oyama G, et al
    The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson's disease.
    PLoS One. 2020;15:e0240491.
    PubMed     Abstract available

  131. KUBOTA M, Kobayashi N, Sugizaki T, Shimoda M, et al
    Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease.
    PLoS One. 2020;15:e0240448.
    PubMed     Abstract available

  132. MORI Y, Yoshikawa E, Futatsubashi M, Ouchi Y, et al
    Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction.
    PLoS One. 2020;15:e0240998.
    PubMed     Abstract available

  133. Retraction: Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and Neurturin In Vitro: Potential therapeutic application for Parkinson's disease in a rhesus monkey model.
    PLoS One. 2020;15:e0242032.

  134. JENG B, Cederberg KLJ, Lai B, Sasaki JE, et al
    Accelerometer output and its association with energy expenditure in persons with mild-to-moderate Parkinson's disease.
    PLoS One. 2020;15:e0242136.
    PubMed     Abstract available

  135. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
    A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    PLoS One. 2020;15:e0240855.
    PubMed     Abstract available

  136. MALINOVA V, Pinter A, Dragaescu C, Rohde V, et al
    The role of intraoperative microelectrode recording and stimulation in subthalamic lead placement for Parkinson's disease.
    PLoS One. 2020;15:e0241752.
    PubMed     Abstract available

  137. MURUGAPPAN M, Alshuaib W, Bourisly AK, Khare SK, et al
    Tunable Q wavelet transform based emotion classification in Parkinson's disease using Electroencephalography.
    PLoS One. 2020;15:e0242014.
    PubMed     Abstract available

  138. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
    Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
    PLoS One. 2020;15:e0243051.
    PubMed     Abstract available

  139. PINTO C, Salazar AP, Hennig EM, Kerr G, et al
    Dual-task walking reduces lower limb range of motion in individuals with Parkinson's disease and freezing of gait: But does it happen during what events through the gait cycle?
    PLoS One. 2020;15:e0243133.
    PubMed     Abstract available

  140. BAUMANN-VOGEL H, Hor H, Poryazova R, Valko P, et al
    REM sleep behavior in Parkinson disease: Frequent, particularly with higher age.
    PLoS One. 2020;15:e0243454.
    PubMed     Abstract available

  141. ANDERSSON N, Nilsson MH, Slaug B, Oswald F, et al
    The meaning of home questionnaire revisited: Psychometric analyses among people with Parkinson's disease reveals new dimensions.
    PLoS One. 2020;15:e0242792.
    PubMed     Abstract available

  142. TORTI M, Fossati C, Casali M, De Pandis MF, et al
    Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study.
    PLoS One. 2020;15:e0243612.
    PubMed     Abstract available

  143. PETROZZIELLO T, Dios AM, Mueller KA, Vaine CA, et al
    SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
    PLoS One. 2020;15:e0243655.
    PubMed     Abstract available

  144. POLAKOVA K, Ruzicka E, Jech R, Kemlink D, et al
    3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson's disease treated with DBS of the STN.
    PLoS One. 2020;15:e0244676.
    PubMed     Abstract available

  145. IBRAHIM A, Ali RAR, Manaf MRA, Ahmad N, et al
    Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial.
    PLoS One. 2020;15:e0244680.
    PubMed     Abstract available

  146. SHIM M, Bang WJ, Oh CY, Lee YS, et al
    Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0244660.
    PubMed     Abstract available

  147. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
    Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    PLoS One. 2020;15:e0244776.
    PubMed     Abstract available

  148. EHLEN F, Al-Fatly B, Kuhn AA, Klostermann F, et al
    Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson's disease.
    PLoS One. 2020;15:e0244148.
    PubMed     Abstract available

  149. PRAVEEN RAJNEESH C, Liou JC, Hsieh TH, Lin JH, et al
    The voiding efficiency in rat models with dopaminergic brain lesions induced through unilateral and bilateral intrastriatal injections.
    PLoS One. 2020;15:e0243452.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.